Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Eli Lilly and Co LLY

Healthcare
Eli Lilly and Company is engaged in drug manufacturing businesses. The Company discovers, develops, manufactures and markets products in the human pharmaceutical products segment. Its diabetes, obesity and other cardiometabolic products include Basaglar, Humalog, Humulin, Jardiance, Mounjaro, Trulicity and Zepbound. Its oncology products include Alimta, Cyramza, Erbitux, Jaypirca, Retevmo... see more

Bullboard (NYSE:LLY)

View:
Post by jboom70on Feb 08, 2024 10:59am

Watching

For healthcare rotation. Looking to enter on pullback.
34
Post by satchmo6on Feb 05, 2024 3:11pm

actually rising

been watching since 2010
50
Post by jw1traderon Sep 28, 2022 3:01pm

stock has been faring very well on the stock market

currently forming a flat base with an ideal buy point of 335.43, according to MarketSmith analysis.   Shares are currently sitting under the 50-day moving average, hitting resistance there ...more  
187
Comment by satchmo6on Sep 17, 2021 11:58am

RE:Putin said he will squash this company

DOWN  2 bucks----its starting------
158
Discussion
Post by Mil_Man54on Dec 26, 2020 8:15am

Bonvoyage12....Lying Pumper

Ignore this clown as he posts lies trying to mislead investors about the actual state of the company...he also posts this same BS on multiple boards
172
Post by SmallCapPaulon Oct 07, 2020 8:34am

Does Emergency Use override safety?

https://www.channelchek.com/news-channel/The_Timing_of_a_COVID_Vaccine
168
Comment by bronkrdron Apr 14, 2020 2:32pm

RE:JAK Inhibitor

Does any one have any news? I'll handle some gossip.
192
Discussion
Post by bronkrdron Apr 13, 2020 11:46am

JAK Inhibitor

An agreement was signed with NIAID  to evaluate its Ollumiant drug as a potential treatment for hospitalized patients diagnosed with CVID-19. Check out the news annoucement.
225
Discussion
Post by bronkrdron Apr 02, 2020 3:54pm

Intersting and developing news

AbCellera and Lilly to Co-develop Antibody Therapies for the Treatment of COVID-19
126
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities